Technical Analysis for HLS - HLS Therapeutics Inc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 3.940 | -4.83% | -0.200 |
HLS closed down 4.83 percent on Friday, May 17, 2024, on 4 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: Jun 7
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 180 Bearish Setup | Bearish Swing Setup | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Wide Bands | Range Expansion | -4.83% | |
| Up 3 Days in a Row | Strength | -4.83% | |
| Up 4 Days in a Row | Strength | -4.83% | |
| Oversold Stochastic | Weakness | -4.83% | |
| Pocket Pivot | Bullish Swing Setup | -0.76% |
| Alert | Time |
|---|---|
| Down 1 ATR | 3 days ago |
| Fell Below Previous Day's Low | 3 days ago |
| Down 3% | 3 days ago |
| Down 2% | 3 days ago |
| Down 1% | 3 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2024-06-07
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. Its lead product is Clozaril, an atypical antipsychotic used in the treatment of schizophrenia. The company also holds the U.S. marketing rights of Absorica, a commercial stage dermatology product. HLS Therapeutics Inc. has a license agreement with Amarin Corporation plc to register, commercialize, and distribute Vascepa capsules in Canada. The company was founded in 2018 and is headquartered in Toronto, Canada.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Life Sciences Pharmaceutical Products Schizophrenia
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Life Sciences Pharmaceutical Products Schizophrenia
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.12 |
| 52 Week Low | 3.34 |
| Average Volume | 11,400 |
| 200-Day Moving Average | 4.522 |
| 50-Day Moving Average | 4.371 |
| 20-Day Moving Average | 4.493 |
| 10-Day Moving Average | 4.230 |
| Average True Range | 0.170 |
| RSI (14) | 35.06 |
| ADX | 27.75 |
| +DI | 27.729 |
| -DI | 45.167 |
| Chandelier Exit (Long, 3 ATRs) | 4.599 |
| Chandelier Exit (Short, 3 ATRs) | 4.281 |
| Upper Bollinger Bands | 5.233 |
| Lower Bollinger Band | 3.752 |
| Percent B (%b) | 0.13 |
| BandWidth | 32.957 |
| MACD Line | -0.145 |
| MACD Signal Line | -0.051 |
| MACD Histogram | -0.0938 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.970 | ||||
| Resistance 3 (R3) | 3.973 | 3.967 | 3.965 | ||
| Resistance 2 (R2) | 3.967 | 3.959 | 3.965 | 3.963 | |
| Resistance 1 (R1) | 3.953 | 3.954 | 3.950 | 3.950 | 3.962 |
| Pivot Point | 3.947 | 3.947 | 3.945 | 3.945 | 3.947 |
| Support 1 (S1) | 3.933 | 3.939 | 3.930 | 3.930 | 3.918 |
| Support 2 (S2) | 3.927 | 3.934 | 3.925 | 3.917 | |
| Support 3 (S3) | 3.913 | 3.927 | 3.915 | ||
| Support 4 (S4) | 3.910 |
